(Q58811115)
Statements
Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes (English)
A Thankamony
P H Tossavainen
D Elleri
R N Dalton
N C Jackson
A M Umpleby
11 December 2013